RecruitingNCT06577857

Inferonasal MIMS® Procedure: Long-Term Follow-Up Extension Study

Minimally Invasive Micro Sclerostomy (MIMS®) Inferonasal Procedure: Long-Term Follow-Up Extension Study

Sponsor

Sanoculis Ltd

Enrollment

53 participants

Start Date

Nov 4, 2022

Study Type

OBSERVATIONAL

Conditions

Open Angle Glaucoma

Summary

A long-term (24 and 30 months) follow-up extension, prospective, non-interventional, open label study for data collection from subjects who underwent prior MIMS® inferonasal surgery, in continuation of the previous clinical investigation with the MIMS® Device (MMS-EEU-5).

Eligibility

Min Age: 40 YearsMax Age: 85 Years

Plain Language Summary

Simplified for easier understanding

This study is a long-term follow-up extension for people who previously had the MIMS glaucoma procedure performed in the lower part of the eye (inferonasal region). The goal is to track how well the procedure continues to work over many years in reducing eye pressure. **You may be eligible if...** - You previously had the inferonasal MIMS procedure - Your surgery was performed at least 24 months before you enroll in this extension study **You may NOT be eligible if...** - You did not previously have the MIMS inferonasal procedure - Your surgery was performed less than 24 months ago Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEInferonasal Minimally Invasive Micro Sclerostomy

The Inferonasal MIMS® procedure uses the proprietary MIMS® device, which creates a sclerostomy in the inferonasal quadrant of the eye.

Locations(1)

S. Malayan Eye Center

Yerevan, Armenia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06577857

Related Trials

24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients

NCT073252401 location

AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension

NCT0449924849 locations

Quality of Life After Glaucoma Surgery: Evaluating the Patient Perspective Across Surgical Options

NCT073032571 location

Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use

NCT072176781 location

Comparative Effectiveness and Safety of ELIOS in Patients With Open-Angle Glaucoma Undergoing Cataract Surgery

NCT0624613616 locations